Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for ACNT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 14.05%
December 31, 2025 17.90%
September 30, 2025 29.29%
June 30, 2025 25.86%
March 31, 2025 16.89%
December 31, 2024 18.92%
September 30, 2024 14.12%
June 30, 2024 12.81%
March 31, 2024 8.08%
December 31, 2023 -166.0%
September 30, 2023 6.25%
June 30, 2023 -1.72%
March 31, 2023 2.56%
December 31, 2022 -80.82%
September 30, 2022 17.94%
June 30, 2022 23.79%
March 31, 2022 19.30%
December 31, 2021 20.05%
September 30, 2021 20.10%
June 30, 2021 16.14%
March 31, 2021 11.54%
December 31, 2020 9.73%
September 30, 2020 7.24%
June 30, 2020 5.37%
March 31, 2020 8.49%
Date Value
December 31, 2019 10.25%
September 30, 2019 9.95%
June 30, 2019 9.96%
March 31, 2019 11.79%
December 31, 2018 14.12%
September 30, 2018 18.03%
June 30, 2018 21.86%
March 31, 2018 19.21%
December 31, 2017 14.50%
September 30, 2017 8.86%
June 30, 2017 15.88%
March 31, 2017 17.54%
December 31, 2016 11.15%
September 30, 2016 13.13%
June 30, 2016 11.45%
March 31, 2016 12.99%
December 31, 2015 9.63%
September 30, 2015 11.91%
June 30, 2015 16.78%
March 31, 2015 17.31%
December 31, 2014 15.56%
September 30, 2014 17.17%
June 30, 2014 15.93%
March 31, 2014 12.19%
December 31, 2013 -0.64%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Solesence, Inc. 25.75%
Olin Corp. 5.03%
Stepan Co. 10.73%
BioLargo, Inc. 38.21%
The Chemours Co. 15.57%

Gross Profit Margin (Quarterly) Related Metrics